Home › Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology
 

Keywords :   


Biotech Weekly: Stories To Track Into SABCS, Oncothyreon And Puma Biotechnology

2015-11-16 19:03:27| Biotech - Topix.net

After discussing Celsion Corporation in my first Stories To Watch Into SABCS, I will discuss upcoming data at SABCS for Oncothyreon and Puma Biotechnology in my second piece. I believe either notable ORR improvement for the ONT-380/T DM1 trial or continued display of promising efficacy trends in the brain metastases patient group could trigger a $5+pps for ONTY.

Tags: track stories weekly biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05USDA moves to electronic identification tags
20.05Better pasture and hay conditions anticipated for 2024
20.05Panasonic offers Fire TV, Google TV and Powered by TiVo
20.05Eutelsat reports results for the period ended 31 March 2024
20.05Producers to be paid grid premiums for AngusLink Beef Scores
20.05WCC Re-elects Tom Bowtell for Second Term as President, Recognizes Contributions of Andy Doyle
20.05May/June 2024 Digital Edition of National Hog Farmer now available
20.05DKSH Extends Distribution Agreement with KRONOS in Asia Pacific
More »